impact:

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

According to PR-model, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer is ranked 127,610th in multilingual Wikipedia, in particular this website is ranked 96,677th in English Wikipedia.

#Language
PR-model F-model AR-model
127,610th place
23,280th place
90,309th place
96,677th place
21,767th place
63,229th place
43,052nd place
34,534th place
29,542nd place
26,523rd place
437th place
14,336th place
22,123rd place
8,180th place
24,337th place